Abstract:Introduction. The increasing prevalence and growing resistance of fungi present a significant peril to public health. There are only four classes of antifungal medicines available today, and few candidates are in clinical trials. Hypothesis/Gap Statement. Rapid and sensitive diagnostic techniques are lacking for most fungal pathogens, and those that do exist are expensive or hard to obtain. Aim. This study aimed to evaluate the feasibility of a novel automated antifungal susceptibility testing system, Fungus AST, in comparison to the broth microdilution method (BMD) recommended by the Clinical and Laboratory Standards Institute (CLSI). Methodology. A total of 101 clinical Candida spp. isolates were collected from the Zengcheng Branch of Nanfang Hospital and subjected to antifungal susceptibility testing. Antifungal susceptibility was assessed using the Fungus AST method and the BMD. Results. In this study, we introduce a novel automated antifungal susceptibility testing system, Fungus AST, which detects the turbidity and/or colour intensity of microdilution wells using a four-wavelength detection technology in real time and is designed to match the growth characteristics of strains over time. Based on our analysis, all reportable ranges of Fungus AST were suitable for clinical fungal isolates in PR China. Within ±twofold dilutions, reproducibility was 100 %. Considering the BMD as a referenced method, ten antifungal agents (anidulafungin, caspofungin, micafungin, fluconazole, voriconazole, posaconazole, itraconazole, amphotericin B, 5-flucytosine and nystatin) showed an essential agreement of >95 %. The category agreement of five antifungal agents (anidulafungin, caspofungin, micafungin, fluconazole and voriconazole) was excellent at >90 %. One Candida albicans isolate and voriconazole showed a major error (ME) (1.7 %), and no other ME or very ME agents were found. Conclusion. Given the above, it can be argued that the utilization of Fungus AST is a discretionary automated approach. More improvements are needed in Fungus AST compared to the BMD system for a wider range of clinical isolates, including different types of fungi.

Detection of the Susceptibility of Eight Kinds of Antifungal Agents in Vitro against Malassezia

Comparative Evaluation of ATB FUNGUS 3 Procedure and CLSI M27-A2 Broth Microdilution Method for Antifungal Susceptibility Testing of Pathogenic Yeasts

In vitro susceptibility testing of eight antifungal agents against pathogenic fungi isolated from superficial mycoses

Inhibition of Four Kinds of Chinese Herb on Malassezia in Vitro

In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller–Hinton Agar Plates

Susceptibility testing of genus Malassezia in vitro to 23 Chinese herbs and the some of their components

A study on therapeutic efficacy of 3 Chinese herbal components on cutaneous Malassezia infection in guinea pigs

In vitro efficacy of antifungal agents alone and in shampoo formulation against dandruff-associated Malassezia spp. and Staphylococcus spp

Analysis of antifungal susceptibility in vitro and fungi distribution in clinics

Response specificity revisited: stress and health status.

Antifungal susceptibility test for pathogenic Fusarium spp in vitro

Evaluation of in vitro antifungal activities of six antifungal agents against dermatophytes

In vitro activities of nine antifungal agents against rare pathogenic fungi.

Susceptibility Test by Berberine Hydrochloride Combined with Antifungal Agents Against Trichophyton Rubrum in Vitro

Antifungal Susceptibility Testing of 100 Clinical Isolates of Pathogenic Yeasts

Research about the Broth Microdilution Antifungal Susceptibility Testing Condition for 182 Microsporum Canis

Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan

Novel automated antifungal susceptibility testing system for yeasts based on dual-detection algorithm of turbidimetry and colorimetry

Random Amplified Polymorphic DNA Combined with Microfluidic Chips in the Identification of Malassezia Species

In vitro and in vivo synergistic inhibition of Malassezia furfur targeting cell membranes by Rosa rugosa Thunb. and Coptidis Rhizoma extracts

Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum